KALVISTA PHARMACEUTICALS INC (KALV) Top Institutional Shareholders
KALVISTA PHARMACEUTICALS INC (KALV) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.39B in KALV holdings during the latest filing period.
Venrock Adviser, Llc is currently the largest disclosed institutional shareholder of KALV tracked by InsiderSet, reporting ownership valued at approximately $130.33M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $174.81M, representing an estimated gain of +34.13% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 53% of the total disclosed KALV value among the investors covered in this analysis. Major shareholders include Venrock Adviser, Llc, Frazier Life Sciences Management, L.P., Suvretta Capital Management, Llc, and several other long-term asset managers with concentrated positions in KALVISTA PHARMACEUTICALS INC (KALV).
This page ranks the largest institutional KALV shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
180
Total Reported Value
$1.39B
Largest Holder
Venrock Adviser, Llc
Largest Position
$130.33M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
188
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Venrock Adviser, Llc | 4.86% | 6,474,485 | $130,331,383 | $174,811,095 | +$44,479,712 | +34.13% | |
| Frazier Life Sciences Management, L.P. | 2.57% | 4,961,108 | $99,867,104 | $133,949,916 | +$34,082,812 | +34.13% | |
| Suvretta Capital Management, Llc | 2.60% | 4,768,712 | $95,994,173 | $128,755,224 | +$32,761,051 | +34.13% | |
| Tang Capital Management Llc | 4.68% | 4,573,530 | $92,065,159 | $123,485,310 | +$31,420,151 | +34.13% | |
| Blackrock, Inc. | 0.00% | 3,795,897 | $76,411,406 | $102,489,219 | +$26,077,813 | +34.13% | |
| Silverarc Capital Management, Llc | 6.82% | 2,876,407 | $57,902,073 | $77,662,989 | +$19,760,916 | +34.13% | |
| Capital World Investors | 0.01% | 2,808,583 | $56,536,776 | $75,831,741 | +$19,294,965 | +34.13% | |
| Point72 Asset Management, L.P. | 0.07% | 2,136,940 | $43,016,602 | $57,697,380 | +$14,680,778 | +34.13% | |
| State Street Corp | 0.00% | 1,955,844 | $39,371,140 | $52,807,788 | +$13,436,648 | +34.13% | |
| Millennium Management Llc | 0.03% | 1,912,146 | $38,491,499 | $51,627,942 | +$13,136,443 | +34.13% | |
| Vestal Point Capital, Lp | 1.04% | 1,850,000 | $37,240,500 | $49,950,000 | +$12,709,500 | +34.13% | |
| Parkman Healthcare Partners Llc | 3.83% | 1,835,506 | $36,948,736 | $49,558,662 | +$12,609,926 | +34.13% | |
| Vanguard Capital Management Llc | 0.00% | 1,830,467 | $36,847,301 | $49,422,609 | +$12,575,308 | +34.13% | |
| Kynam Capital Management, Lp | 2.33% | 1,820,954 | $36,655,804 | $49,165,758 | +$12,509,954 | +34.13% | |
| Woodline Partners Lp | 0.11% | 1,509,920 | $30,394,690 | $40,767,840 | +$10,373,150 | +34.13% | |
| Octagon Capital Advisors Lp | 3.23% | 1,450,000 | $29,188,500 | $39,150,000 | +$9,961,500 | +34.13% | |
| Emerald Advisers, Llc | 0.81% | 1,264,023 | $25,444,783 | $34,128,621 | +$8,683,838 | +34.13% | |
| Armistice Capital, Llc | 0.82% | 1,236,000 | $24,880,680 | $33,372,000 | +$8,491,320 | +34.13% | |
| Elmind Capital, Lp | 5.84% | 1,021,300 | $20,558,769 | $27,575,100 | +$7,016,331 | +34.13% | |
| Geode Capital Management, Llc | 0.00% | 996,235 | $20,059,823 | $26,898,345 | +$6,838,522 | +34.09% | |
| Squadron Capital Management Llc | 7.93% | 985,100 | $19,830,063 | $26,597,700 | +$6,767,637 | +34.13% | |
| Spruce Street Capital Lp | 4.34% | 897,681 | $18,070,319 | $24,237,387 | +$6,167,068 | +34.13% | |
| Freestone Grove Partners Lp | 0.13% | 882,906 | $17,772,898 | $23,838,462 | +$6,065,564 | +34.13% | |
| Goldman Sachs Group Inc | 0.00% | 824,293 | $16,593,018 | $22,255,911 | +$5,662,893 | +34.13% | |
| Emerald Mutual Fund Advisers Trust | 0.79% | 805,762 | $16,219,989 | $21,755,574 | +$5,535,585 | +34.13% | |
| Great Point Partners Llc | 3.33% | 675,000 | $13,587,750 | $18,225,000 | +$4,637,250 | +34.13% | |
| Bank Of New York Mellon Corp | 0.00% | 584,347 | $11,762,906 | $15,777,369 | +$4,014,463 | +34.13% | |
| Driehaus Capital Management Llc | 0.08% | 564,039 | $11,354,105 | $15,229,053 | +$3,874,948 | +34.13% | |
| Bank Of America Corp | 0.00% | 555,628 | $11,184,791 | $15,001,956 | +$3,817,165 | +34.13% | |
| Barclays Plc | 0.00% | 537,061 | $10,811,038 | $14,500,647 | +$3,689,609 | +34.13% | |
| Ubs Group Ag | 0.00% | 515,650 | $10,380,034 | $13,922,550 | +$3,542,516 | +34.13% | |
| Schroder Investment Management Group | 0.01% | 506,743 | $9,303,801 | $13,682,061 | +$4,378,260 | +47.06% | |
| Morgan Stanley | 0.00% | 439,099 | $8,839,072 | $11,855,673 | +$3,016,601 | +34.13% | |
| Catalio Capital Management, Lp | 1.79% | 426,551 | $8,586,472 | $11,516,877 | +$2,930,405 | +34.13% | |
| Hennion & Walsh Asset Management, Inc. | 0.25% | 375,995 | $7,568,779 | $10,151,865 | +$2,583,086 | +34.13% | |
| Northern Trust Corp | 0.00% | 363,694 | $7,321,161 | $9,819,738 | +$2,498,577 | +34.13% | |
| Vanguard Portfolio Management Llc | 0.00% | 362,900 | $7,305,177 | $9,798,300 | +$2,493,123 | +34.13% | |
| Seb Asset Management Ab | 0.03% | 351,305 | $7,071,761 | $9,485,235 | +$2,413,474 | +34.13% | |
| Charles Schwab Investment Management Inc | 0.00% | 323,451 | $6,511,069 | $8,733,177 | +$2,222,108 | +34.13% | |
| Schonfeld Strategic Advisors Llc | 0.05% | 315,537 | $6,351,758 | $8,519,499 | +$2,167,741 | +34.13% | |
| Jefferies Financial Group Inc. | 0.07% | 286,046 | $5,758,106 | $7,723,242 | +$1,965,136 | +34.13% | |
| Ishara Investments Lp | 5.63% | 276,750 | $5,570,978 | $7,472,250 | +$1,901,272 | +34.13% | |
| Vanguard Fiduciary Trust Co | 0.00% | 276,391 | $5,563,751 | $7,462,557 | +$1,898,806 | +34.13% | |
| Dafna Capital Management Llc | 1.22% | 267,402 | $5,382,802 | $7,219,854 | +$1,837,052 | +34.13% | |
| Atom Investors Lp | 0.35% | 245,993 | $4,951,839 | $6,641,811 | +$1,689,972 | +34.13% | |
| Citigroup Inc | 0.00% | 244,261 | $4,916,974 | $6,595,047 | +$1,678,073 | +34.13% | |
| Ameriprise Financial Inc | 0.00% | 229,984 | $4,629,577 | $6,209,568 | +$1,579,991 | +34.13% | |
| F/M Investments Llc | 0.30% | 226,991 | $4,569,329 | $6,128,757 | +$1,559,428 | +34.13% | |
| Blue Owl Capital Holdings Lp | 1.16% | 215,000 | $4,327,950 | $5,805,000 | +$1,477,050 | +34.13% | |
| Fmr Llc | 0.00% | 187,848 | $3,781,383 | $5,071,896 | +$1,290,513 | +34.13% |
Frequently asked questions about KALV
Who owns the most KALV stock?
The largest holders of KALV are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for KALVISTA PHARMACEUTICALS INC (KALV).
Is KALV widely held by superinvestors?
Many widely followed stocks like KALV appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly KALV is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.